Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 18;10(9):e0138088.
doi: 10.1371/journal.pone.0138088. eCollection 2015.

Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012

Collaborators, Affiliations

Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012

Matthijs van der Steen et al. PLoS One. .

Abstract

We investigated time trends in extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from different patient settings in The Netherlands from 2008-2012. E. coli and K. pneumoniae isolates from blood and urine samples of patients > = 18 years were selected from the Dutch Infectious Disease Surveillance System-Antimicrobial Resistance (ISIS-AR) database. We used multivariable Poisson regression to study the rate per year of blood stream infections by susceptible and resistant isolates, and generalized estimating equation (GEE) log-binomial regression for trends in the proportion of extended-spectrum cephalosporin-resistant isolates. Susceptibility data of 197,513 E. coli and 38,244 K. pneumoniae isolates were included. The proportion of extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates from urine and blood samples increased in all patient settings, except for K. pneumoniae isolates from patients admitted to intensive care units. For K. pneumoniae, there was a different time trend between various patient groups (p<0.01), with a significantly higher increase in extended-spectrum cephalosporin-resistant isolates from patients attending a general practitioner than in isolates from hospitalized patients. For E. coli, the increasing time trends did not differ among different patient groups. This nationwide study shows a general increase in extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates. However, differences in trends between E. coli en K. pneumoniae underline the importance of E. coli as a community-pathogen and its subsequent influence on hospital resistance level, while for K. pneumoniae the level of resistance within the hospital seems less influenced by the resistance trends in the community.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The rate of bloodstream infections by Escherichia coli and Klebsiella pneumoniae (A) and the rate of bloodstream infections by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae (B) from 2008–2012, ISIS-AR, the Netherlands, adjusted for patient characteristics, including age, gender, patient setting and geographic region.
The plots show the point-estimates and log-linear trends generated by a Poisson regression with robust standard error.
Fig 2
Fig 2. The proportion (in %) of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates, for blood isolates (A), male urine isolates (B) and female urine isolates (C) from 2008–2012, ISIS-AR, the Netherlands.
The point-estimates and log-linear trends per year were estimated with a generalized estimation equation (GEE) for log-binominal regression including time in years, and patient characteristics, including age, gender, patient setting and geographic region. The error bars represent the 95% confident intervals of each of the point-estimates.
Fig 3
Fig 3. The proportion (in %) extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates, for blood isolates (A), male urine isolates (B) and female urine isolates (C), per patient setting (general practitioner [GP], outpatient department [OPD], inpatient department [IPD] and intensive care units [ICU]), from 2008–2012, ISIS-AR, the Netherlands.
The point-estimates are generated with a generalized estimation equation (GEE) for log-binominal regression, including time in years, and patient characteristics, including age, gender, and geographic region. The error bars represent the 95% confident intervals of each of the point-estimates. To produce plots with comparable y-axis, the upper error bar is cut-off for some of the point-estimates.

References

    1. Paterson DL, Bonomo RA. (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657–686. - PMC - PubMed
    1. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. (2006) Impact of extended-spectrum b-lactamase–producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27: 1226–1232. - PubMed
    1. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, KIM EC, et al. (2004) Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 38: 4574–4581. - PMC - PubMed
    1. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. (2006) Clinical and economic impact of bacteremia with extended- spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50: 1257–1262. - PMC - PubMed
    1. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. (2007) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165–174. - PubMed

Publication types

MeSH terms